{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:56:45Z","timestamp":1792029405171,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["Department of Health and Human Services (HHS) Contract Number HHSF223201810022I Task Order 75F40119F19002"],"award-info":[{"award-number":["Department of Health and Human Services (HHS) Contract Number HHSF223201810022I Task Order 75F40119F19002"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40264-021-01113-8","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T01:03:44Z","timestamp":1632963824000},"page":"1151-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6502-5212","authenticated-orcid":false,"given":"Keran","family":"Moll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Lee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Fingar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Hobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minya","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda O.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Shoaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"1113_CR1","unstructured":"Feibus K, Goldkind SF. Pregnant women and clinical trials: scientific, regulatory, and ethical considerations. 18 Oct 2010. http:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/WomensHealthResearch\/UCM243540.ppt. Accessed 20 Sep 2019"},{"key":"1113_CR2","unstructured":"Food and Drug Administration, Center for Biologics Evaluation and Research. Development and licensure of vaccines to prevent COVID-19: guidance for industry. Jun 2020. https:\/\/www.fda.gov\/media\/139638\/download. Accessed 23 Nov 2020"},{"issue":"44","key":"1113_CR3","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","volume":"69","author":"LD Zambrano","year":"2020","unstructured":"Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Ton VT, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22\u2013October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm6944e3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"1113_CR4","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","volume":"384","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273\u201382. https:\/\/doi.org\/10.1056\/NEJMoa2104983.","journal-title":"N Engl J Med"},{"issue":"23","key":"1113_CR5","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.2021.7563","volume":"325","author":"AY Collier","year":"2021","unstructured":"Collier AY, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J, et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA. 2021;325(23):2370\u201380. https:\/\/doi.org\/10.1001\/jama.2021.7563.","journal-title":"JAMA"},{"issue":"2","key":"1113_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/AOG.0000000000004457","volume":"138","author":"ED Shanes","year":"2021","unstructured":"Shanes ED, Otero S, Mithal LB, Mupanomunda CA, Miller ES, Goldstein JA. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in pregnancy: measures of immunity and placental histopathology. Obstet Gynecol. 2021;138(2):281\u20133. https:\/\/doi.org\/10.1097\/AOG.0000000000004457.","journal-title":"Obstet Gynecol"},{"key":"1113_CR7","unstructured":"Embryogenesis and fetal morphological development. In: Cunningham F, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al., editors. Williams obstetrics. 24th ed. New York: McGraw Hill; 2014. pp. 127\u2013153."},{"issue":"11","key":"1113_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/bdra.23573","volume":"106","author":"EC Ailes","year":"2016","unstructured":"Ailes EC, Simeone RM, Dawson AL, Petersen EE, Gilboa SM. Using insurance claims data to identify and estimate critical periods in pregnancy: an application to antidepressants. Birth Defects Res A Clin Mol Teratol. 2016;106(11):927\u201334. https:\/\/doi.org\/10.1002\/bdra.23573.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"1113_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/aje\/kwy237","volume":"188","author":"ST Bird","year":"2019","unstructured":"Bird ST, Toh S, Sahin L, Andrade SE, Gelperin K, Taylor L, et al. Misclassification in assessment of first trimester in-utero exposure to drugs used proximally to conception: the example of letrozole utilization for infertility treatment. Am J Epidemiol. 2019;188(2):418\u201325. https:\/\/doi.org\/10.1093\/aje\/kwy237.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1113_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s40471-017-0104-1","volume":"4","author":"SE Andrade","year":"2017","unstructured":"Andrade SE, B\u00e9rard A, Nordeng HME, Wood ME, van Gelder MMHJ, Toh S. Administrative claims data versus augmented pregnancy data for the study of pharmaceutical treatments in pregnancy. Curr Epidemiol Rep. 2017;4(2):106\u201316. https:\/\/doi.org\/10.1007\/s40471-017-0104-1.","journal-title":"Curr Epidemiol Rep."},{"issue":"1","key":"1113_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pds.3319","volume":"22","author":"SE Andrade","year":"2013","unstructured":"Andrade SE, Scott PE, Davis RL, Li D-K, Getahun D, Cheetham TC, et al. Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf. 2013;22(1):7\u201315. https:\/\/doi.org\/10.1002\/pds.3319.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1113_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/pds.4556","volume":"27","author":"P-O Bloti\u00e8re","year":"2018","unstructured":"Bloti\u00e8re P-O, Weill A, Dalichampt M, Billionnet C, Mezzarobba M, Raguideau F, et al. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: an application to antiepileptic drug use in 4.9 million pregnant women in France. Pharmacoepidemiol Drug Saf. 2018;27(7):763\u201370. https:\/\/doi.org\/10.1002\/pds.4556.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1113_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1475-6773.2006.00635.x","volume":"42","author":"MC Hornbrook","year":"2007","unstructured":"Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R, et al. Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res. 2007;42(2):908\u201327. https:\/\/doi.org\/10.1111\/j.1475-6773.2006.00635.x.","journal-title":"Health Serv Res"},{"issue":"5","key":"1113_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/pds.3407","volume":"22","author":"Q Li","year":"2013","unstructured":"Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, et al. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013;22(5):524\u201332. https:\/\/doi.org\/10.1002\/pds.3407.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1113_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/pds.3284","volume":"22","author":"AV Margulis","year":"2013","unstructured":"Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hern\u00e1ndez-D\u00edaz S. Algorithms to estimate beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(5):16\u201324. https:\/\/doi.org\/10.1002\/pds.3284.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1113_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192033","volume":"13","author":"A Matcho","year":"2018","unstructured":"Matcho A, Ryan P, Fife D, Gifkins D, Knoll C, Friedman A. Inferring pregnancy episodes and outcomes within a network of observational databases. PLoS ONE. 2018;13(2): e0192033. https:\/\/doi.org\/10.1371\/journal.pone.0192033.","journal-title":"PLoS ONE"},{"issue":"8","key":"1113_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/pds.3467","volume":"22","author":"RT Mikolajczyk","year":"2013","unstructured":"Mikolajczyk RT, Kraut AA, Garbe E. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD). Pharmacoepidemiol Drug Saf. 2013;22(8):873\u201380. https:\/\/doi.org\/10.1002\/pds.3467.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"27","key":"1113_CR18","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.vaccine.2013.03.069","volume":"31","author":"AL Naleway","year":"2013","unstructured":"Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, et al. Identifying pregnancy episodes, outcomes, and mother\u2013infant pairs in the Vaccine Safety Datalink. Vaccine. 2013;31(27):2898\u2013903. https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.069.","journal-title":"Vaccine"},{"issue":"49","key":"1113_CR19","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1016\/j.vaccine.2016.07.007","volume":"34","author":"CE Jones","year":"2016","unstructured":"Jones CE, Munoz FM, Kochhar S, Vergnano S, Cutland CL, Steinhoff M, et al. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine. 2016;34(49):6007\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.007.","journal-title":"Vaccine"},{"issue":"49","key":"1113_CR20","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1016\/j.vaccine.2016.07.032","volume":"34","author":"CE Jones","year":"2016","unstructured":"Jones CE, Munoz FM, Spiegel HML, Heininger U, Zuber PLF, Edwards KM, et al. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. Vaccine. 2016;34(49):5998\u20136006. https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.032.","journal-title":"Vaccine"},{"issue":"49","key":"1113_CR21","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1016\/j.vaccine.2016.03.045","volume":"34","author":"JA Quinn","year":"2016","unstructured":"Quinn JA, Munoz FM, Gonik B, Frau L, Cutland C, Mallett-Moore T, et al. Preterm birth: case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2016;34(49):6047\u201356. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.045.","journal-title":"Vaccine"},{"issue":"48 Pt A","key":"1113_CR22","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1016\/j.vaccine.2017.01.047","volume":"35","author":"CE Rouse","year":"2017","unstructured":"Rouse CE, Eckert LO, Babarinsa I, Fay E, Gupta M, Harrison MS, et al. Spontaneous abortion and ectopic pregnancy: case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017;35(48 Pt A):6563\u201374. https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.047.","journal-title":"Vaccine"},{"issue":"49","key":"1113_CR23","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1016\/j.vaccine.2016.03.044","volume":"34","author":"FT Da Silva","year":"2016","unstructured":"Da Silva FT, Gonik B, McMillan M, Keech C, Dellicour S, Bhange S, et al. Stillbirth: case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2016;34(49):6057\u201368. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.044.","journal-title":"Vaccine"},{"issue":"4","key":"1113_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10995-007-0256-6","volume":"12","author":"EV Kuklina","year":"2008","unstructured":"Kuklina EV, Whiteman MK, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J. 2008;12(4):469\u201377. https:\/\/doi.org\/10.1007\/s10995-007-0256-6.","journal-title":"Matern Child Health J"},{"key":"1113_CR25","unstructured":"Moll K, Wong H-L, Fingar K, Hobbi S, Sheng M, Burrell T, et al. Study protocol: validating pregnancy outcomes and gestational age in a claims-EMR linked database version 2.6. Food and Drug Administration. Jun 2020. https:\/\/www.bestinitiative.org\/wp-content\/uploads\/2020\/08\/Validating_Pregnancy_Outcomes_Linked_Database_Protocol_2020-1.pdf. Accessed 11 Jun 2021"},{"key":"1113_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4817","volume":"364","author":"MH Murad","year":"2019","unstructured":"Murad MH, Wang Z, Chu H, Lin L. When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation. BMJ. 2019;364: k4817. https:\/\/doi.org\/10.1136\/bmj.k4817.","journal-title":"BMJ"},{"key":"1113_CR27","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates; 1988."},{"key":"1113_CR28","unstructured":"Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2016. National Vital Statistics Reports. Volume 67, Number 1. National Center for Health Statistics. 2018. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr67\/nvsr67_01.pdf. Accessed 14 Oct 2020"},{"key":"1113_CR29","unstructured":"Centers for Disease Control and Prevention. Data and statistics. Page last reviewed 13 Aug 2020. https:\/\/www.cdc.gov\/ncbddd\/stillbirth\/data.html. Accessed 11 Jun 2021"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01113-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-021-01113-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01113-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T10:16:58Z","timestamp":1635416218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-021-01113-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s40264-021-01113-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"8 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the US Food and Drug Administration through the Department of Health and Human Services (HHS) Contract Number HHSF223201810022I Task Order 75F40119F19002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Keran Moll, Hui Lee Wong, Kathryn Fingar, Shayan Hobbi, Minya Sheng, Timothy A. Burrell, Linda O. Eckert, Flor M. Munoz, Bethany Baer, Azadeh Shoaibi, and Steven Anderson declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"All data supporting the findings of this study are available within the article and its supplementary information files.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Programming codes are available upon request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Keran Moll, Hui Lee Wong, Kathryn Fingar, Shayan Hobbi, Timothy A. Burrell, Linda O. Eckert, Flor M. Munoz, and Azadeh Shoaibi contributed to the study conception and design. Acquisition of data was performed by Keran Moll, Shayan Hobbi, and Minya Sheng. Analysis and interpretation of data were conducted by Keran Moll, Hui Lee Wong, Kathryn Fingar, Shayan Hobbi, Timothy A. Burrell, Bethany Baer, Azadeh Shoaibi, and Steven Anderson. All authors contributed to drafting or revising the article. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}